{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:07:19Z","timestamp":1795111639380,"version":"4.10.3"},"reference-count":102,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,20]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Prostate cancer (PCa) presents a significant global health challenge, and cachexia in end-stage PCa further reduces survival time and deteriorates patient quality of life. This necessitates nuanced approaches to prevention, diagnosis, and treatment. This review analyzes the complex role of growth differentiation factor 15 (GDF15) in various aspects of PCa, including metabolism, chemoresistance, metastasis, and clinical implications. Mechanically, the interactions of GDF15 with PCa lipid metabolism and stromal activation are hypothesized to drive PCa progression and promote cachexia. GDF15\u2019s role in PCa bone metastasis is mediated through interactions with osteoblasts and osteoclasts. Furthermore, GDF15\u2019s role in chemoresistance emphasizes its impact on drug responses and suggests a potential therapeutic target. Clinically, GDF15 has shown potential as a biomarker, offering diagnostic precision and prognostic value, particularly when combined with established markers such as prostate-specific antigen. The review concludes with a discussion on several monoclonal antibodies targeting GDF15 in clinical trials, such as AV-380, NGM120, Visugromab, and AZD8853, highlighting promising strategies for novel therapies and precision medicine.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000003876","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T05:00:13Z","timestamp":1764046813000},"page":"211-221","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Decoding GDF15: Impact on prostate cancer metabolism, chemoresistance, and clinical applications"],"prefix":"10.1097","volume":"139","author":[{"given":"Weizhen","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Xu","sequence":"additional","affiliation":[{"name":"Sichuan Clinical Research Center for Urological and Kidney Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Xiong","sequence":"additional","affiliation":[{"name":"West China Medical School, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Li","sequence":"additional","affiliation":[{"name":"West China Medical School, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dechao","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weichao","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"R1-20260407","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1097\/CM9.0000000000003442","article-title":"Comparative analysis of cancer statistics in China and the United States in 2024","volume":"137","author":"Wu","year":"2024","journal-title":"Chin Med J"},{"key":"R2-20260407","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41419-022-05392-6","article-title":"SR9009 inhibits lethal prostate cancer subtype 1 by regulating the LXR\u03b1\/FOXM1 pathway independently of REV-ERBs","volume":"13","author":"Xu","year":"2022","journal-title":"Cell Death Dis"},{"key":"R3-20260407","doi-asserted-by":"crossref","first-page":"29349","DOI":"10.1007\/s11356-022-24266-0","article-title":"Analysis of the distribution characteristics of prostate cancer and its environmental factors in China","volume":"30","author":"Zhang","year":"2023","journal-title":"Environ Sci Pollut Res Int"},{"key":"R4-20260407","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41574-021-00529-7","article-title":"GDF15: Emerging biology and therapeutic applications for obesity and cardiometabolic disease","volume":"17","author":"Wang","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"R5-20260407","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1128\/MCB.20.10.3742-3751.2000","article-title":"Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury","volume":"20","author":"Hsiao","year":"2000","journal-title":"Mol Cell Biol"},{"key":"R6-20260407","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cytogfr.2021.11.002","article-title":"Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia","volume":"64","author":"Siddiqui","year":"2022","journal-title":"Cytokine Growth Factor Rev"},{"key":"R7-20260407","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/jcp.22196","article-title":"Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer","volume":"224","author":"Mimeault","year":"2010","journal-title":"J Cell Physiol"},{"key":"R8-20260407","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1158\/0008-5472.CAN-05-4067","article-title":"Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer","volume":"66","author":"Bauskin","year":"2006","journal-title":"Cancer Res"},{"key":"R9-20260407","doi-asserted-by":"crossref","DOI":"10.1038\/srep12870","article-title":"Growth differentiation factor-15: A p53- and demethylation-upregulating gene represses cell proliferation, invasion, and tumorigenesis in bladder carcinoma cells","volume":"5","author":"Tsui","year":"2015","journal-title":"Sci Rep"},{"key":"R10-20260407","article-title":"Role of GDF15 in methylseleninic acid-mediated inhibition of cell proliferation and induction of apoptosis in prostate cancer cells","volume":"14","author":"Zhang","year":"2019","journal-title":"PLoS One"},{"key":"R11-20260407","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1158\/1055-9965.EPI-05-0752","article-title":"Aberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis","volume":"15","author":"Rasiah","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R12-20260407","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10654-021-00828-3","article-title":"Ageing-related markers and risks of cancer and cardiovascular disease: A prospective study in the EPIC-Heidelberg cohort","volume":"37","author":"Srour","year":"2022","journal-title":"Eur J Epidemiol"},{"key":"R13-20260407","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/sj.bjc.6600869","article-title":"Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1)\u202fgene expression in human prostatic tissues","volume":"88","author":"Nakamura","year":"2003","journal-title":"Br J Cancer"},{"key":"R14-20260407","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1432-0436.2006.00142.x","article-title":"Dynamics of expression of growth differentiation factor 15 in normal and PIN development in the mouse","volume":"75","author":"Noorali","year":"2007","journal-title":"Differentiation"},{"key":"R15-20260407","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","article-title":"MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily","volume":"94","author":"Bootcov","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"R16-20260407","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1128\/MCB.20.10.3742-3751.2000","article-title":"Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury","volume":"20","author":"Hsiao","year":"2000","journal-title":"Mol Cell Biol"},{"key":"R17-20260407","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.bcp.2012.11.025","article-title":"The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1\/GDF15) in cancer","volume":"85","author":"Wang","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"R18-20260407","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/jir.2009.0052","article-title":"The TGF-beta superfamily cytokine MIC-1\/GDF15: Secretory mechanisms facilitate creation of latent stromal stores","volume":"30","author":"Bauskin","year":"2010","journal-title":"J Interferon Cytokine Res"},{"key":"R19-20260407","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/pros.10365","article-title":"Down-regulation of macrophage inhibitory cytokine-1\/prostate derived factor in benign prostatic hyperplasia","volume":"59","author":"Kakehi","year":"2004","journal-title":"Prostate"},{"key":"R20-20260407","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.trecan.2022.01.004","article-title":"Emerging signaling mediators in the anorexia-cachexia syndrome of cancer","volume":"8","author":"Talbert","year":"2022","journal-title":"Trends Cancer"},{"key":"R21-20260407","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1158\/0008-5472.CAN-04-1216","article-title":"Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis","volume":"64","author":"Cheung","year":"2004","journal-title":"Cancer Res"},{"key":"R22-20260407","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/pros.20551","article-title":"Prostate-derived factor as a paracrine and autocrine factor for the proliferation of androgen receptor-positive human prostate cancer cells","volume":"67","author":"Chen","year":"2007","journal-title":"Prostate"},{"key":"R23-20260407","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0006-291X(03)00823-4","article-title":"Dysregulated expression of MIC-1\/PDF in human prostate tumor cells","volume":"305","author":"Karan","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"R24-20260407","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.7150\/jca.51059","article-title":"A novel set of immune-associated gene signature predicts biochemical recurrence in localized prostate cancer patients after radical prostatectomy","volume":"12","author":"Luan","year":"2021","journal-title":"J Cancer"},{"key":"R25-20260407","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002787","article-title":"GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma","volume":"9","author":"Wang","year":"2021","journal-title":"J Immunother Cancer"},{"key":"R26-20260407","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216184","article-title":"YKL-40\u202fderived from infiltrating macrophages cooperates with GDF15 to establish an immune suppressive microenvironment in gallbladder cancer","volume":"563","author":"Wang","year":"2023","journal-title":"Cancer Lett"},{"key":"R27-20260407","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1038\/s41467-023-39817-3","article-title":"Tumor-derived GDF-15 blocks LFA-1\u202fdependent T cell recruitment and suppresses responses to anti-PD-1 treatment","volume":"14","author":"Haake","year":"2023","journal-title":"Nat Commun"},{"key":"R28-20260407","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043833","article-title":"Macrophage inhibitory cytokine-1 (MIC-1\/GDF15)\u202fslows cancer development but increases metastases in TRAMP prostate cancer prone mice","volume":"7","author":"Husaini","year":"2012","journal-title":"PLoS One"},{"key":"R29-20260407","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233846","article-title":"Growth differentiation factor-15\u202fslows the growth of murine prostate cancer by stimulating tumor immunity","volume":"15","author":"Husaini","year":"2020","journal-title":"PLoS One"},{"key":"R30-20260407","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1158\/2326-6066.CIR-17-0049","article-title":"Intratumoral STING activation with T-cell checkpoint modulation generates systemic antitumor immunity","volume":"5","author":"Ager","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"R31-20260407","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115189","article-title":"Macrophage inhibitory cytokine-1 (MIC-1\/GDF15)\u202fgene deletion promotes cancer growth in TRAMP prostate cancer prone mice","volume":"10","author":"Husaini","year":"2015","journal-title":"PLoS One"},{"key":"R32-20260407","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0014-5793(00)01291-6","article-title":"Profile of gene expression regulated by induced p53: Connection to the TGF-beta family","volume":"470","author":"Kannan","year":"2000","journal-title":"FEBS Lett"},{"key":"R33-20260407","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8278039","article-title":"CRP Stimulates GDF15 expression in endothelial cells through p53","volume":"2018","author":"Kim","year":"2018","journal-title":"Mediators Inflamm"},{"key":"R34-20260407","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.3390\/cancers12103043","article-title":"The role of GDF15 in regulating the canonical pathways of the tumor microenvironment in wild-type p53 ovarian tumor and its response to chemotherapy","volume":"12","author":"Izaguirre","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R35-20260407","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109501","article-title":"GDF15\u202fmediates the metabolic effects of PPAR\u03b2\/\u03b4 by activating AMPK","volume":"36","author":"Aguilar-Recarte","year":"2021","journal-title":"Cell Rep"},{"key":"R36-20260407","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.3390\/cancers14194591","article-title":"Increased density of growth differentiation factor-15+ immunoreactive M1\/M2\u202fmacrophages in prostate cancer of different Gleason scores compared with benign prostate hyperplasia","volume":"14","author":"Bonaterra","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R37-20260407","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41467-023-36325-2","article-title":"Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses","volume":"14","author":"Hirz","year":"2023","journal-title":"Nat Commun"},{"key":"R38-20260407","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/carcin\/bgaa065","article-title":"The interplay of growth differentiation factor 15 (GDF15) expression and M2\u202fmacrophages during prostate carcinogenesis","volume":"41","author":"Sadasivan","year":"2020","journal-title":"Carcinogenesis"},{"key":"R39-20260407","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1097\/01.ju.0000142058.99614.ff","article-title":"The role of inflammation in the pathogenesis of prostate cancer","volume":"172","author":"Nelson","year":"2004","journal-title":"J Urol"},{"key":"R40-20260407","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/pros.22911","article-title":"Reduced expression of GDF-15 is associated with atrophic inflammatory lesions of the prostate","volume":"75","author":"Lambert","year":"2015","journal-title":"Prostate"},{"key":"R41-20260407","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1002\/cam4.3850","article-title":"Growth and differentiation factor 15 and NF-\u03baB expression in benign prostatic biopsies and risk of subsequent prostate cancer detection","volume":"10","author":"Rybicki","year":"2021","journal-title":"Cancer Med"},{"key":"R42-20260407","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1038\/s41467-023-39817-3","article-title":"Tumor-derived GDF-15 blocks LFA-1\u202fdependent T cell recruitment and suppresses responses to anti-PD-1 treatment","volume":"14","author":"Haake","year":"2023","journal-title":"Nat Commun"},{"key":"R43-20260407","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1158\/1541-7786.MCR-10-0342","article-title":"NSAID inhibition of prostate cancer cell migration is mediated by Nag-1 Induction via the p38 MAPK-p75(NTR) pathway","volume":"8","author":"Wynne","year":"2010","journal-title":"Mol Cancer Res"},{"key":"R44-20260407","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1158\/0008-5472.CAN-13-2259","article-title":"Local and systemic protumorigenic effects of cancer-associated fibroblast-derived GDF15","volume":"74","author":"Bruzzese","year":"2014","journal-title":"Cancer Res"},{"key":"R45-20260407","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","article-title":"Matrix crosslinking forces tumor progression by enhancing integrin signaling","volume":"139","author":"Levental","year":"2009","journal-title":"Cell"},{"key":"R46-20260407","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fphys.2017.00097","article-title":"Glucose metabolism in the progression of prostate cancer","volume":"8","author":"Cutruzzol\u00e0","year":"2017","journal-title":"Front Physiol"},{"key":"R47-20260407","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3390\/metabo11110765","article-title":"Fatty acid metabolism reprogramming in advanced prostate cancer","volume":"11","author":"Xu","year":"2021","journal-title":"Metabolites"},{"key":"R48-20260407","doi-asserted-by":"crossref","first-page":"56051","DOI":"10.18632\/oncotarget.17359","article-title":"Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade","volume":"8","author":"Flaig","year":"2017","journal-title":"Oncotarget"},{"key":"R49-20260407","doi-asserted-by":"crossref","first-page":"38264","DOI":"10.18632\/oncotarget.16123","article-title":"Lipid degradation promotes prostate cancer cell survival","volume":"8","author":"Itkonen","year":"2017","journal-title":"Oncotarget"},{"key":"R50-20260407","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/cac2.12137","article-title":"Macrophage inhibitory cytokine-1 induced by a high-fat diet promotes prostate cancer progression by stimulating tumor-promoting cytokine production from tumor stromal cells","volume":"41","author":"Huang","year":"2021","journal-title":"Cancer Commun (Lond)"},{"key":"R51-20260407","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.cell.2019.07.033","article-title":"GDF15 is an inflammation-induced central mediator of tissue tolerance","volume":"178","author":"Luan","year":"2019","journal-title":"Cell"},{"key":"R52-20260407","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S2213-8587(13)70152-9","article-title":"Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): A randomised controlled trial","volume":"2","author":"Preiss","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R53-20260407","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41586-019-1911-y","article-title":"GDF15\u202fmediates the effects of metformin on body weight and energy balance","volume":"578","author":"Coll","year":"2020","journal-title":"Nature"},{"key":"R54-20260407","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/nm.4392","article-title":"GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates","volume":"23","author":"Mullican","year":"2017","journal-title":"Nat Med"},{"key":"R55-20260407","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/ctrv.2001.0219","article-title":"Ovarian cancer chemotherapy","volume":"27","author":"Christian","year":"2001","journal-title":"Cancer Treat Rev"},{"key":"R56-20260407","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100938","article-title":"Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms","volume":"68","author":"Li","year":"2023","journal-title":"Drug Resist Updat"},{"key":"R57-20260407","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1200\/JCO.22.02804","article-title":"Flashback foreword: Cisplatin\/pemetrexed in non-small-cell lung cancer","volume":"41","author":"Stinchcombe","year":"2023","journal-title":"J Clin Oncol"},{"key":"R58-20260407","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/17512433.2017.1338138","article-title":"Treatment strategies for DNA repair-deficient prostate cancer","volume":"10","author":"Teply","year":"2017","journal-title":"Expert Rev Clin Pharmacol"},{"key":"R59-20260407","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.3390\/cancers14092107","article-title":"Molecular mechanisms and current treatment options for cancer cachexia","volume":"14","author":"Ahmad","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R60-20260407","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/nm1677","article-title":"Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1","volume":"13","author":"Johnen","year":"2007","journal-title":"Nat Med"},{"key":"R61-20260407","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cmet.2020.10.023","article-title":"GDF-15 neutralization alleviates platinum-based chemotherapy-induced emesis, anorexia, and weight loss in mice and nonhuman primates","volume":"32","author":"Breen","year":"2020","journal-title":"Cell Metab"},{"key":"R62-20260407","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41586-023-06921-9","article-title":"GDF15 linked to maternal risk of nausea and vomiting during pregnancy","volume":"625","author":"Fejzo","year":"2024","journal-title":"Nature"},{"key":"R63-20260407","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/jcsm.12077","article-title":"MAP3K11\/GDF15 axis is a critical driver of cancer cachexia","volume":"7","author":"Lerner","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R64-20260407","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.molmed.2017.10.005","article-title":"Targeting obesity and cachexia: Identification of the GFRAL receptor-MIC-1\/GDF15 pathway","volume":"23","author":"Breit","year":"2017","journal-title":"Trends Mol Med"},{"key":"R65-20260407","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/s41591-020-0945-x","article-title":"Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice","volume":"26","author":"Suriben","year":"2020","journal-title":"Nat Med"},{"key":"R66-20260407","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/pcmedi\/pbab003","article-title":"Neuroendocrine cells of the prostate: Histology, biological functions, and molecular mechanisms","volume":"4","author":"Butler","year":"2021","journal-title":"Precis Clin Med"},{"key":"R67-20260407","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/pros.20460","article-title":"Epidermal growth factor receptor (ErbB1) expression in prostate cancer progression: Correlation with androgen independence","volume":"66","author":"Shah","year":"2006","journal-title":"Prostate"},{"key":"R68-20260407","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1158\/0008-5472.CAN-16-1656","article-title":"HER2 and EGFR overexpression support metastatic progression of prostate cancer to bone","volume":"77","author":"Day","year":"2017","journal-title":"Cancer Res"},{"key":"R69-20260407","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41419-022-05090-3","article-title":"N-glycosylation of GDF15 abolishes its inhibitory effect on EGFR in AR inhibitor-resistant prostate cancer cells","volume":"13","author":"Wang","year":"2022","journal-title":"Cell Death Dis"},{"key":"R70-20260407","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1056\/NEJMoa040720","article-title":"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer","volume":"351","author":"Tannock","year":"2004","journal-title":"N Engl J Med"},{"key":"R71-20260407","doi-asserted-by":"crossref","first-page":"7696","DOI":"10.1158\/0008-5472.CAN-08-4901","article-title":"Identification of candidate biomarkers of therapeutic response to docetaxel by proteomic profiling","volume":"69","author":"Zhao","year":"2009","journal-title":"Cancer Res"},{"key":"R72-20260407","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1158\/1078-0432.CCR-07-1037","article-title":"Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy: Identification of a cytoprotective mechanism involving growth differentiation factor 15","volume":"13","author":"Huang","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R73-20260407","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1124\/jpet.105.100081","article-title":"Drug-induced expression of nonsteroidal anti-inflammatory drug-activated gene\/macrophage inhibitory cytokine-1\/prostate-derived factor, a putative tumor suppressor, inhibits tumor growth","volume":"318","author":"Martinez","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"R74-20260407","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/pcan.2012.6","article-title":"Growth\/differentiation factor-15: prostate cancer suppressor or promoter?","volume":"15","author":"Va\u0148hara","year":"2012","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R75-20260407","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/bjc.2012.484","article-title":"Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1","volume":"108","author":"Mimeault","year":"2013","journal-title":"Br J Cancer"},{"key":"R76-20260407","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000599","article-title":"A proteomic atlas of senescence-associated secretomes for aging biomarker development","volume":"18","author":"Basisty","year":"2020","journal-title":"PLoS Biol"},{"key":"R77-20260407","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133668","article-title":"The senescence-associated secretome as an indicator of age and medical risk","volume":"5","author":"Schafer","year":"2020","journal-title":"JCI Insight"},{"key":"R78-20260407","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14111","article-title":"Downregulation of PLIN2 in human dermal fibroblasts impairs mitochondrial function in an age-dependent fashion and induces cell senescence via GDF15","volume":"23","author":"Chiariello","year":"2024","journal-title":"Aging Cell"},{"key":"R79-20260407","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/febs.17087","article-title":"Mitochondrial dysfunction and cisplatin sensitivity in gastric cancer: GDF15 as a master player","volume":"291","author":"Cavinato","year":"2024","journal-title":"FEBS J"},{"key":"R80-20260407","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13013","article-title":"Senescence-associated tissue microenvironment promotes colon cancer formation through the secretory factor GDF15","volume":"18","author":"Guo","year":"2019","journal-title":"Aging Cell"},{"key":"R81-20260407","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMra1701695","article-title":"Metastatic prostate cancer","volume":"378","author":"Sartor","year":"2018","journal-title":"N Engl J Med"},{"key":"R82-20260407","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/jbmr.3618","article-title":"Understanding the bone in cancer metastasis","volume":"33","author":"Fornetti","year":"2018","journal-title":"J Bone Miner Res"},{"key":"R83-20260407","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.juro.2008.04.140","article-title":"Histopathological assessment of prostate cancer bone osteoblastic metastases","volume":"180","author":"Roudier","year":"2008","journal-title":"J Urol"},{"key":"R84-20260407","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.trecan.2020.09.006","article-title":"Emerging players in prostate cancer-bone niche communication","volume":"7","author":"Furesi","year":"2021","journal-title":"Trends Cancer"},{"key":"R85-20260407","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ccell.2015.04.009","article-title":"The TGF-\u03b2 signaling regulator PMEPA1\u202fsuppresses prostate cancer metastases to bone","volume":"27","author":"Fournier","year":"2015","journal-title":"Cancer Cell"},{"key":"R86-20260407","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41556-021-00641-w","article-title":"TGF-\u03b2-induced DACT1 biomolecular condensates repress Wnt signalling to promote bone metastasis","volume":"23","author":"Esposito","year":"2021","journal-title":"Nat Cell Biol"},{"key":"R87-20260407","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41413-021-00178-6","article-title":"GDF15 promotes prostate cancer bone metastasis and colonization through osteoblastic CCL2 and RANKL activation","volume":"10","author":"Siddiqui","year":"2022","journal-title":"Bone Res"},{"key":"R88-20260407","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1038\/s41388-019-0736-3","article-title":"Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion","volume":"38","author":"Wang","year":"2019","journal-title":"Oncogene"},{"key":"R89-20260407","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/onc.2009.420","article-title":"Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK-RhoA signaling pathway","volume":"29","author":"Senapati","year":"2010","journal-title":"Oncogene"},{"key":"R90-20260407","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1158\/1078-0432.CCR-05-1331","article-title":"Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis","volume":"12","author":"Brown","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R91-20260407","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1073\/pnas.0530278100","article-title":"Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum","volume":"100","author":"Welsh","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R92-20260407","doi-asserted-by":"crossref","first-page":"6214","DOI":"10.7150\/thno.55676","article-title":"A panel of selected serum protein biomarkers for the detection of aggressive prostate cancer","volume":"11","author":"Song","year":"2021","journal-title":"Theranostics"},{"key":"R93-20260407","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.juro.2014.07.098","article-title":"Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance","volume":"193","author":"Radtke","year":"2015","journal-title":"J Urol"},{"key":"R94-20260407","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.7150\/thno.23180","article-title":"Genes involved in prostate cancer progression determine MRI visibility","volume":"8","author":"Li","year":"2018","journal-title":"Theranostics"},{"key":"R95-20260407","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1158\/1078-0432.CCR-08-3126","article-title":"Macrophage inhibitory cytokine 1: A new prognostic marker in prostate cancer","volume":"15","author":"Brown","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R96-20260407","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.humpath.2023.03.001","article-title":"Mass spectrometry-based assessment of prostate cancer-associated crystalloids reveals enrichment for growth and differentiation factor 15","volume":"135","author":"Tekin","year":"2023","journal-title":"Hum Pathol"},{"key":"R97-20260407","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1158\/1078-0432.CCR-23-1631","article-title":"A Phase 1b first-in-patient study assessing the safety, tolerability, pharmacokinetics and pharmacodynamics of ponsegromab in participants with cancer and cachexia","volume":"30","author":"Crawford","year":"2024","journal-title":"Clin Cancer Res"},{"key":"R98-20260407","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1158\/1538-7445.AM2015-1153","article-title":"Effective treatment of cancer associated cachexia by AV-380, a GDF15 inhibitory antibody","volume":"75","author":"Lerner","year":"2015","journal-title":"Cancer Res"},{"key":"R99-20260407","doi-asserted-by":"crossref","first-page":"S610","DOI":"10.1016\/j.annonc.2021.08.1072","article-title":"550P Initial results of a phase Ia\/Ib study of NGM120, a first-in-class anti-GDNF family receptor alpha like (GFRAL) antibody in patients (pts) with advanced solid tumors","volume":"32","author":"Jain","year":"2021","journal-title":"Ann Oncol"},{"key":"R100-20260407","doi-asserted-by":"crossref","first-page":"S1186","DOI":"10.1016\/j.annonc.2022.07.1888","article-title":"1402P Initial results of a cohort of advanced prostate cancer patients in a phase Ia study of NGM120, a first-in-class anti-GDNF family receptor alpha like (GFRAL) antibody","volume":"33","author":"Medic","year":"2022","journal-title":"Ann Oncol"},{"key":"R101-20260407","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1200\/JCO.2023.41.16_suppl.2501","article-title":"Initial results from the phase 2A trial of visugromab (CTL-002)+ nivolumab in advanced\/metastatic anti-PD1\/-L1 relapsed\/refractory solid tumors (The GDFATHER-TRIAL)","volume":"41","author":"Melero Bermejo","year":"2023","journal-title":"Am Soc Clin Oncol"},{"key":"R102-20260407","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1158\/1538-7445.AM2021-1828","article-title":"AZD8853: A novel antibody targeting GDF15 for immunotherapy refractory tumors","volume":"81","author":"Hurt","year":"2021","journal-title":"Cancer Res"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CM9.0000000000003876","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:24:53Z","timestamp":1785767093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CM9.0000000000003876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":102,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000003876","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"2024-11-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}